Is MannKind Corporation Stock Really Worth the Risk?

Shares of MannKind Corporation (NASDAQ:MNKD) rocketed more than 41% higher yesterday.MannKind does have an earnings report on the horizon, but quarterly figures aren’t expected until mid-March.For those that don’t know, MannKind is a biopharmaceutical company that makes a unique inhalable insulin product.